RxDoctor Payments Data

John Anderson, DO

Family Medicine · Morris, MNNPI 1003303439

Payments from drug & device makers

$241in general payments, 2019–2025

Across 14 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$72
  • Bayer$41
  • Novartis$29
  • Novo Nordisk$27
  • Boehringer Ingelheim$25
  • Johnson & Johnson$15
  • plus $32 from 3 others

What the payments were for

  • Food & beverage$241100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$241 in reported general payments places this provider in the 80th percentile of 1,162 family medicine providers in Minnesota.

See all family medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$2,921
Medicare patients
19
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin69$58,199
EliquisApixaban63$35,179
OzempicSemaglutide31$31,679
XareltoRivaroxaban33$23,057
RybelsusSemaglutide15$21,966
MounjaroTirzepatide14$14,990
Spiriva RespimatTiotropium Bromide20$10,545
Tresiba Flextouch U-200Insulin Degludec15$8,976
Semglee (Yfgn) PenInsulin Glargine-Yfgn15$4,758
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$3,639
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate18$2,843
Humalog Kwikpen U-100Insulin Lispro18$2,603
Metoprolol Succinate195$2,143
Gabapentin173$2,059
Levothyroxine Sodium240$1,756

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$25$68,74389 claims
Novo NordiskOzempic, Rybelsus$27$53,64546 claims
Johnson & JohnsonXarelto$15$23,05733 claims
Lilly USA, LLCMounjaro$12$14,99014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,162 family medicine providers in Minnesota.

Other family medicine in Morris

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →